Changing natalizumab dosing frequency reduced risk for PML

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Changing natalizumab dosing frequency reduced risk for PML

Post by MSUK »

Changing natalizumab dosing frequency reduced risk for Progressive Multifocal Leukoencephalopathy (PML)

A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health in New York…Read more - http://www.ms-uk.org/changing-natalizum ... opathy-pml

Image
MS-UK - http://www.ms-uk.org/
Top
ElliotB
Family Elder
Posts: 2100
Joined: Mon Feb 03, 2014 4:08 pm

Re: Changing natalizumab dosing frequency reduced risk for P

Post by ElliotB »

I have to wonder why anyone would take a medication known to cause or potentially cause something as serious as PML. This is not the only medication that has this very, very serious risk.
Top
Post Reply

Return to “Tysabri (Antegren, Natalizumab)”